ATLANTA, Aug. 29, 2024 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Sage Therapeutics, Inc. (“Sage Therapeutics” or “the Company”) (NASDAQ: SAGE). The lawsuit alleges that defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts about the Company’s business, operations and prospects, including claims that: (i) zuranolone was less effective in treating major depressive disorder (“MDD”) than defendants led investors to believe; (ii) as a result, the FDA would likely not approve the New Drug Application (“NDA”) for zuranolone for the treatment of MDD as presented and overstated zuranolone’s clinical results for MDD and its overall regulatory and commercial prospects; (iii) SAGE-718 was less effective in treating mild cognitive impairment (“MCI”) due to Parkinson’s disease (“PD”) than Defendants led investors to believe; (iv) accordingly, the clinical, regulatory and commercial prospects of SAGE-718 as a treatment for MCI due to PD were overstated; (v) SAGE-324 was less effective in treating essential tremor (“ET”) than Defendants led investors to believe; and (vi) accordingly, the clinical, regulatory and commercial prospects of SAGE-324 as a treatment for ET were overstated.
If you bought shares of Sage Therapeutics between 12 April 2021 and 23 July 2024and you have suffered a significant loss on that investment, you should discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected] or toll free at (888) 508-6832, or visit the firm’s website at. www.holzerlaw.com/case/sage-therapeutics/ to find out more.
The deadline to ask the court to appoint him as lead plaintiff in the case is October 28, 2024.
Holzer & Holzer, LLC, a top-rated securities litigation law firm by ISS for 2021, 2022 and 2023, is dedicated to vigorously representing shareholders and investors in nationwide litigation, including shareholder class actions and derivative litigation. Since its founding in 2000, Holzer & Holzer’s attorneys have played a critical role in recovering hundreds of millions of dollars for shareholders who have been victims of corporate fraud and other misconduct. More information about the firm is available on its website, www.holzerlaw.com, and by contacting the firm. Holzer & Holzer, LLC paid for the distribution of this promotional communication, and Corey Holzer is the attorney responsible for its content.
CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll free)
[email protected]
